Elekta Customers See Their Ideas Brought to Life at ESTRO 29

By Elekta, PRNE
Wednesday, September 8, 2010

Unique Hologram Theatre Shows Translation of Customer Input into Practical Clinical Solutions

BARCELONA, Spain, September 9, 2010 - Elekta will demonstrate its continued leadership role in the
technological advancement of radiation oncology at the 2010 meeting of the
European Society for Therapeutic Radiology and Oncology (ESTRO) 12-16
September in Barcelona, Spain. Elekta's theme is Experience the Elekta
Difference, which acknowledges the importance of listening to customers and
delivering what they need-in image guidance, digital control, field shaping,
respiratory motion management, treatment speed and accuracy.

"Our Experience the Elekta Difference theme distinguishes Elekta from
other providers," says Olof Sanden, Executive Vice President, Europe and
AFLAME. "We believe our customers should be the principle drivers of
innovation based on their clinical needs. The difference is how Elekta
translates listening and collaboration with customers into practical
solutions that our customers can employ in the clinic."

To bring its ESTRO 29 theme to life, Elekta booth #040 will feature a 3D
hologram theatre designed to show visitors how the company's tradition of
listening has equipped clinicians with the tools they need to optimize
patient care. Elekta also will exhibit several new, developing and
field-proven solutions, including:

    - Agility* multileaf collimator (MLC) prototype. Featuring a leaf
      positioning system that utilizes optical technology to verify and
      ensure accuracy, Agility will provide low transmission with
      unparalleled leaf speed. In addition, Agility will offer 160, 5mm
      leaves across the full 40 x 40cm field to provide a single, versatile
      MLC for a spectrum of applications. To download a white paper
      highlighting the scientific principles used to design Agility, visit

    - Integrity(TM)* digital linear accelerator control. Now in its sixth
      generation, Elekta's digital linac control synchronizes multiple linac
      operations through a single centralized control system to increase
      performance and reduce the risk of errors. To download a white paper
      detailing three clinical sites' experience with Integrity, visit

    - Intuity(TM) image guidance for tumors and critical structures. Building
      upon Elekta's XVI imaging technology, Intuity offers superior image
      quality combined with the largest available image size.

    - Symmetry(TM) respiratory motion management for lung tumor treatment.
      Revolutionizing the process of visualizing moving tumors during
      treatment, Symmetry enables clinicians to reduce margins, account for
      baseline shifts and employ uninterrupted treatment delivery while the
      patient breathes freely.

    - Monaco(R) treatment planning with VMAT. With reduced planning time and
      increased clinical throughput, Monaco with VMAT optimizes single or
      multiple non-coplanar arcs simultaneously, providing the flexibility
      and control needed for complex treatment plans.

    - Clarity(TM)** soft tissue visualization. Capable of integrating with
      any linac platform, Clarity takes breast and prostate soft tissue
      visualization for planning and patient set-up to new levels. Easy to
      learn and use, Clarity seamlessly integrates within existing clinical

    - Leksell Gamma Knife(R) Perfexion(TM) stereotactic radiosurgery system
      for treatment of multiple metastases with speed and precision.

Events held in conjunction with ESTRO

Prior to ESTRO, Elekta will host its 2010 European Users Meeting
Saturday, 11 September at the Pullman Skipper Hotel. An interactive forum,
attendees will have the opportunity to hear customers share their clinical
experience utilizing Elekta's advanced treatment methodologies, adaptive and
enhanced planning tools and oncology information systems. In addition, Elekta
will host two lunch symposia:

    - Elekta Oncology: Innovations in Image Guidance and VMAT, Tuesday, 14
      September from 12:45 - 14:30 in Room 113, Level 1.

    - Elekta Neuroscience: Solutions for Stereotactic Radiotherapy,
      Wednesday, 15 September from 12:45 - 14:30 in Room 115, Level 1.

To learn more about Elekta's innovations at ESTRO, visit

*Works in progress and not available for sale or distribution.

**Clarity is not for sale or distribution in all regions. Please contact
your local Elekta representative or authorized distributor for further

About Elekta

Elekta is a human care company pioneering significant innovations and
clinical solutions for treating cancer and brain disorders. The company
develops sophisticated, state-of-the-art tools and treatment planning systems
for radiation therapy and radiosurgery, as well as workflow enhancing
software systems across the spectrum of cancer care.

Stretching the boundaries of science and technology, providing
intelligent and resource-efficient solutions that offer confidence to both
healthcare providers and patients, Elekta aims to improve, prolong and even
save patient lives, making the future possible.

Today, Elekta solutions in oncology and neurosurgery are used in over
5,000 hospitals globally, and every day more than 100,000 patients receive
diagnosis, treatment or follow-up with the help of a solution from the Elekta

Elekta employs around 2,500 employees globally. The corporate headquarter
is located in Stockholm, Sweden, and the company is listed on the Nordic
Exchange under the ticker EKTAb. For more information about Elekta, please
visit www.elekta.com.

Stina Thorman, Vice President Corporate Communications, Elekta AB, +46-8-587-254-37, email: stina.thorman at elekta.com, Time zone: CET: Central European; Michelle Lee, Director, Global Public Relations and Brand Management, Elekta, +1-770-670-2447, michelle.lee at elekta.com, Time zone: EDT: Eastern Daylight

will not be displayed